Clinical Trial: The Effect of DA9301 on Tablet Computer-Induced Asthenopia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Clinical Trial to Investigate the Effect of DA9301 on Tablet Computer-induced Asthenopia in Humans

Brief Summary: Asthenopia or eye strain describes nonspecific symptoms of an eye when it is tired from intensive work. Vaccinium uliginosum is a flowering plant in the genus Vaccinium. This plant is native to cool temperature regions of the Northern Hemisphere. Considering its antioxidative ingredients, the extract of Vaccinium uliginosum is expected to play a significant role in treating various ocular pathologies. The investigators performed a randomized, case-controlled study in healthy subjects and investigated the protective effect of Vaccinium uliginosum extract (DA-9301) on tablet computer-induced asthenopia.

Detailed Summary:
Sponsor: Namyi Gu

Current Primary Outcome: Change of the modified questionnaire scores proposed by Ames et al. [ Time Frame: before and immediately after tablet computer use on Day 0 and Day 29 (deviation window: Day 21-31) ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: DongGuk University

Dates:
Date Received: December 21, 2015
Date Started: January 2014
Date Completion:
Last Updated: December 28, 2015
Last Verified: December 2015